Inactive

The Medical Readiness Contracting Office – Pacific, in support of Tripler Army Medical Center, Hawaii, intends to make a sole source award to Illumina, Inc. for the purchase of the following Viral Sur... The Medical Readiness Contracting Office – Pacific, in support of Tripler Army Medical Center, Hawaii, intends to make a sole source award to Illumina, Inc. for the purchase of the following Viral Surveillance Panel Kits for use with Government-Owned Illumina MiSeq Systems: Illumina Viral Surveillance Panel v2 Kit, Sets A, B, C, and D; MiSeq Reagent Kit v3; NextSeq 1000/2000 P1 XLEAP-SBS Reagent Kits; Illumina RNA Fast Hyb Enrichment. The statutory authority permitting this award without providing full and open competition is FAR 13.106-1(b)(1) which authorizes the government for purchases not exceeding the simplified acquisition threshold (SAT), to solicit from one source if the Contracting Officer determines that the circumstances of the contract action deem only one source reasonably available. The NAICS code is 541714. This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. All questions and responses concerning this notice shall be emailed to megumi.kuwada.civ@health.mil. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.